Position in NEO
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,885,956
+$1,673,745 QoQ
Shares Held
254,172
+1561.3% QoQ
Ownership
0.195%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NEO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026RENAISSANCE TECHNOLOGIES LLC holds $770,315,587 across 28 Diagnostics & Research names. NEO ranks #18 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MEDP |
Medpace Holdings, Inc.
|
504,668 | $242,336,526 | |
| 2 | DHR |
Danaher Corp /De/
|
678,808 | $128,701,996 | |
| 3 | ILMN |
Illumina, Inc.
|
972,642 | $119,887,852 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
138,964 | $68,304,974 | |
| 5 | NTRA |
Natera, Inc.
|
197,500 | $39,498,025 | |
| 6 | A |
Agilent Technologies, Inc.
|
300,300 | $34,228,194 | |
| 7 | GH |
Guardant Health, Inc.
|
337,600 | $31,184,112 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
48,504 | $27,253,912 |
All Filings in NEO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,885,956 | 254,172 | Shares | Sole | 2026-05-14 | |
| 2024-06-30 | $212,211 | 15,300 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,225,952 | 141,600 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,614,764 | 99,800 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,744,130 | 223,100 | Shares | Sole | 2023-11-14 | |
| 2022-03-31 | $2,988,900 | 246,000 | Shares | Sole | 2022-05-13 | |
| No filing history on record for this holder in this stock. | ||||||